Understanding how a specific protein affects glioblastoma cells
Determining the Mechanisms of RING1- and YY1-binding protein (RYBP) function and dysregulation in glioblastoma cells
This study is looking at a protein called RYBP to see how it helps fight glioblastoma, a tough type of brain cancer, and why it’s often less active in patients; by understanding this, researchers hope to find new ways to treat the disease.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Winthrop University NIH-funded |
| Lab location | 1 site (Rock Hill, United States) |
| Project ID | NIH-10936126 on NIH RePORTER |
What this research studies
This research investigates the role of the RING1- and YY1-binding protein (RYBP) in glioblastoma, a highly aggressive brain tumor. The study aims to uncover how RYBP functions as a tumor suppressor and why its expression is often reduced in glioblastoma patients. Researchers will use advanced techniques to manipulate RYBP levels in glioblastoma cells and analyze the resulting changes in cell behavior, such as growth and movement. By identifying the genes regulated by RYBP, the research hopes to pave the way for new targeted therapies for glioblastoma.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with glioblastoma who may benefit from new therapeutic strategies targeting RYBP.
Not a fit: Patients with other types of brain tumors or those not diagnosed with glioblastoma may not receive benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for glioblastoma, potentially improving patient survival rates.
How similar studies have performed: While the specific role of RYBP in glioblastoma is still being explored, similar approaches targeting gene regulation in cancer have shown promise in other studies.
Where this research is happening
Rock Hill, United States
- Winthrop University — Rock Hill, United States (Active)
Researchers
- Principal investigator: Stovall, Daniel Brooks — Winthrop University
- Study coordinator: Stovall, Daniel Brooks
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.